Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men. Sildenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. Sildenafil treats erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Sildenafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow easily.
Viatris is a global healthcare company dedicated to helping people around the world live healthier lives at every stage of life. The company's differentiated product portfolio includes branded, generic and complex generic medicines across multiple therapeutic areas. Viatris better serves customers and patients in more than 165 countries and territories. TEVA has been committed to developing and producing medicines to help improve people's lives. TEVA strives to be a global leader in generic and specialty medicines, with a portfolio of 3,500 products in virtually every therapeutic area. About 200 million people around the world take Teva medicines every day. In addition to the company's position in generics, the company has significant innovative research and operations that support the company's growing portfolio of specialty and biopharmaceutical products. Viatris is one of the major players operating in the Sildenafil market, holding a share of 29.03% in 2023.
By type, 50mg/Tablets segment accounted for the largest share of market in 2022.
By application, the Retail Pharmacies segment occupied the biggest share from 2018 to 2022.
Sildenafil Industry Trends At present, with the reform of the medical and health system entering a new stage and the continuous development of the generic drug market, there are more and more Sildenafil market participants. The market competition of Sildenafil is becoming more and more fierce, which puts great pressure on the development of some Sildenafil enterprises. Under heavy pressure, some Sildenafil companies began to use various methods to improve their competitiveness. If industry companies cannot maintain their leading advantages in technological innovation, new product development, and cost control, the company's products face the risk of a decline in product gross profit margins. To this end, companies in the Sildenafil industry need to further accelerate new product upgrade iterations and achieve product differentiation through R&D innovation and increased R&D investment. For example, from the perspective of product innovation, Sildenafil has continuously strengthened Sildenafil's research on other indications. For example, on February 5, 2020, Pfizer's Revatio® was approved by the National Medical Products Administration (NMPA) of China, becoming the first phosphodiesterase type 5 (PDE-5) inhibitor approved in China for the treatment of pulmonary arterial hypertension. For the treatment of pulmonary hypertension in adults. In addition, Sildenafil has continuously strengthened research on new dosage forms. For example, oral suspensions have the potential to provide a more convenient treatment option for people with swallowing difficulties than tablet formulations. In general, the continuous strengthening of Sildenafil research is one of the trends in the development of the industry. Market Challenges The threat of substitute products At present, there are many kinds of drugs for the treatment of erectile dysfunction on the market, mainly including Sildenafil, Tadalafil, Vardenafil and so on. Among them, Tadalafil takes effect within about half an hour to one hour after oral administration, and the drug effect may last for 36 hours. Tadalafil is a phosphodiesterase type V inhibitor that promotes erections by increasing blood flow to the penis. Compared with Sildenafil, Tadalafil has the advantages of lower dose, longer half-life, longer duration of drug, and is not affected by high-fat diet and alcohol consumption. At present, in clinical use, Tadalafil has better development prospects due to its better clinical performance, and may replace Sildenafil. The threat posed by alternative products such as Tadalafil is one of the challenges facing the development of the industry.
This report elaborates on the current development of the Sildenafil industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Viatris
Aurobindo
Baiyunshan Pharma
TEVA
Bristol Laboratories
Jiangsu Yabang Epson Pharmaceutical Co, Ltd
By Type:
Others
100mg/Tablets
50mg/Tablets
By Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Sildenafil Market Overview 2018-2029
-
1.1 China Sildenafil Industry Development Overview
-
1.2 China Sildenafil Industry Development History
-
1.3 China Sildenafil Industry Market Size (2018-2029)
-
1.4 China Sildenafil Market Analysis by Type from Production Side
-
1.4.1 China Sildenafil Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Sildenafil Production Volume, Production Value and Growth Rate of 100mg/Tablets (2018-2029)
-
1.4.3 China Sildenafil Production Volume, Production Value and Growth Rate of 50mg/Tablets (2018-2029)
-
1.5 China Sildenafil Market Analysis by Application from Consumption End
-
1.5.1 China Sildenafil Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.2 China Sildenafil Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.3 China Sildenafil Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.6 China Sildenafil Market Analysis by Region
-
1.6.1 North China Sildenafil Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Sildenafil Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Sildenafil Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Sildenafil Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Sildenafil Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Sildenafil Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Sildenafil Market Size and Growth Rate from 2018-2029
Chapter 2 China Sildenafil Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Sildenafil Market Status and Competition at home and abroad in 2023
-
2.2.2 China Sildenafil Market Status and Competition Analysis in 2023
-
2.2.3 China Sildenafil Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Sildenafil Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Sildenafil Industry Development
Chapter 3 SildenafilIndustry Chain Analysis
-
3.1 Sildenafil Industry Chain
-
3.2 Sildenafil Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Sildenafil Market
-
3.3 Sildenafil Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Sildenafil Market
Chapter 4 China Sildenafil Market, by Type
-
4.1 China Sildenafil Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Sildenafil Total Production Volume and Growth Rate from Production Side
-
4.5 China Sildenafil Production Volume and Growth Rate, by Type
-
4.5.1 China Sildenafil Production Volume and Growth Rate of Others
-
4.5.2 China Sildenafil Production Volume and Growth Rate of 100mg/Tablets
-
4.5.3 China Sildenafil Production Volume and Growth Rate of 50mg/Tablets
Chapter 5 China Sildenafil Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Sildenafil Total Market Size and Growth Rate from Consumption End
-
5.5 China Sildenafil Market Size and Growth Rate, by Application
-
5.5.1 China Sildenafil Market Size and Growth Rate of Hospital Pharmacies
-
5.5.2 China Sildenafil Market Size and Growth Rate of Retail Pharmacies
-
5.5.3 China Sildenafil Market Size and Growth Rate of Online Pharmacies
Chapter 6 China Sildenafil Market, by Region
-
6.1 China Sildenafil Production Volume and Production Value, by Region
-
6.2 China Sildenafil Sales Volume and Sales Value, by Region
Chapter 7 North China Sildenafil Market Analysis
-
7.1 North China Sildenafil Market, by Type
-
7.2 North China Sildenafil Market, by Application
Chapter 8 Central China Sildenafil Market Analysis
-
8.1 Central China Sildenafil Market, by Type
-
8.2 Central China Sildenafil Market, by Application
Chapter 9 South China Sildenafil Market Analysis
-
9.1 South China Sildenafil Market, by Type
-
9.2 South China Sildenafil Market, by Application
Chapter 10 East China Sildenafil Market Analysis
-
10.1 East China Sildenafil Market, by Type
-
10.2 East China Sildenafil Market, by Application
Chapter 11 Northeast China Sildenafil Market Analysis
-
11.1 Northeast China Sildenafil Market, by Type
-
11.2 Northeast China Sildenafil Market, by Application
Chapter 12 Southwest China Sildenafil Market Analysis
-
12.1 Southwest China Sildenafil Market, by Type
-
12.2 Southwest China Sildenafil Market, by Application
Chapter 13 Northwest China Sildenafil Market Analysis
-
13.1 Northwest China Sildenafil Market, by Type
-
13.2 Northwest China Sildenafil Market, by Application
Chapter 14 Company Profiles
-
14.1 Viatris
-
14.1.1 Viatris Company Profile
-
14.1.2 Viatris Sildenafil Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Aurobindo
-
14.2.1 Aurobindo Company Profile
-
14.2.2 Aurobindo Sildenafil Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Baiyunshan Pharma
-
14.3.1 Baiyunshan Pharma Company Profile
-
14.3.2 Baiyunshan Pharma Sildenafil Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 TEVA
-
14.4.1 TEVA Company Profile
-
14.4.2 TEVA Sildenafil Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bristol Laboratories
-
14.5.1 Bristol Laboratories Company Profile
-
14.5.2 Bristol Laboratories Sildenafil Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Jiangsu Yabang Epson Pharmaceutical Co, Ltd
-
14.6.1 Jiangsu Yabang Epson Pharmaceutical Co, Ltd Company Profile
-
14.6.2 Jiangsu Yabang Epson Pharmaceutical Co, Ltd Sildenafil Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Sildenafil Industry Research Conclusions
-
15.2 Sildenafil Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Sildenafil Industry Market Size (2018-2029)
-
Figure China Sildenafil Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Sildenafil Production Volume, Production Value and Growth Rate of 100mg/Tablets (2018-2029)
-
Figure China Sildenafil Production Volume, Production Value and Growth Rate of 50mg/Tablets (2018-2029)
-
Figure China Sildenafil Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Sildenafil Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Sildenafil Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure North China Sildenafil Market Size and Growth Rate from 2018-2029
-
Figure Central China Sildenafil Market Size and Growth Rate from 2018-2029
-
Figure South China Sildenafil Market Size and Growth Rate from 2018-2029
-
Figure East China Sildenafil Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Sildenafil Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Sildenafil Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Sildenafil Market Size and Growth Rate from 2018-2029
-
Figure Sildenafil Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Sildenafil Market Share by Type in 2018
-
Figure China Sildenafil Market Share by Type in 2023
-
Figure China Sildenafil Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Sildenafil Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Sildenafil Production Volume and Growth Rate of 100mg/Tablets (2018-2023)
-
Figure China Sildenafil Production Volume and Growth Rate of 50mg/Tablets (2018-2023)
-
Figure China Sildenafil Market Share by Application in 2018
-
Figure China Sildenafil Market Share by Application in 2023
-
Figure China Sildenafil Total Market Size and Growth Rate from Consumption End
-
Figure China Sildenafil Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Sildenafil Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Sildenafil Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Table China Sildenafil Production Volume by Region (2018-2023)
-
Table China Sildenafil Production Volume Share by Region (2018-2023)
-
Figure China Sildenafil Production Volume Share by Region (2018-2023)
-
Table China Sildenafil Production Value by Region (2018-2023)
-
Table China Sildenafil Production Value Share by Region (2018-2023)
-
Figure China Sildenafil Production Value Share by Region (2018-2023)
-
Table China Sildenafil Sales Volume by Region (2018-2023)
-
Table China Sildenafil Sales Volume Share by Region (2018-2023)
-
Figure China Sildenafil Sales Volume Share by Region (2018-2023)
-
Table China Sildenafil Sales Value by Region (2018-2023)
-
Table China Sildenafil Sales Value Share by Region (2018-2023)
-
Figure China Sildenafil Sales Value Share by Region (2018-2023)
-
Table North China Sildenafil Production Volume by Type (2018-2023)
-
Table North China Sildenafil Production Volume Share by Type (2018-2023)
-
Figure North China Sildenafil Production Volume Share by Type (2018-2023)
-
Table North China Sildenafil Sales Volume by Application (2018-2023)
-
Table North China Sildenafil Sales Volume Share by Application (2018-2023)
-
Figure North China Sildenafil Sales Volume Share by Application (2018-2023)
-
Table Central China Sildenafil Production Volume by Type (2018-2023)
-
Table Central China Sildenafil Production Volume Share by Type (2018-2023)
-
Figure Central China Sildenafil Production Volume Share by Type (2018-2023)
-
Table Central China Sildenafil Sales Volume by Application (2018-2023)
-
Table Central China Sildenafil Sales Volume Share by Application (2018-2023)
-
Figure Central China Sildenafil Sales Volume Share by Application (2018-2023)
-
Table South China Sildenafil Production Volume by Type (2018-2023)
-
Table South China Sildenafil Production Volume Share by Type (2018-2023)
-
Figure South China Sildenafil Production Volume Share by Type (2018-2023)
-
Table South China Sildenafil Sales Volume by Application (2018-2023)
-
Table South China Sildenafil Sales Volume Share by Application (2018-2023)
-
Figure South China Sildenafil Sales Volume Share by Application (2018-2023)
-
Table East China Sildenafil Production Volume by Type (2018-2023)
-
Table East China Sildenafil Production Volume Share by Type (2018-2023)
-
Figure East China Sildenafil Production Volume Share by Type (2018-2023)
-
Table East China Sildenafil Sales Volume by Application (2018-2023)
-
Table East China Sildenafil Sales Volume Share by Application (2018-2023)
-
Figure East China Sildenafil Sales Volume Share by Application (2018-2023)
-
Table Northeast China Sildenafil Production Volume by Type (2018-2023)
-
Table Northeast China Sildenafil Production Volume Share by Type (2018-2023)
-
Figure Northeast China Sildenafil Production Volume Share by Type (2018-2023)
-
Table Northeast China Sildenafil Sales Volume by Application (2018-2023)
-
Table Northeast China Sildenafil Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Sildenafil Sales Volume Share by Application (2018-2023)
-
Table Southwest China Sildenafil Production Volume by Type (2018-2023)
-
Table Southwest China Sildenafil Production Volume Share by Type (2018-2023)
-
Figure Southwest China Sildenafil Production Volume Share by Type (2018-2023)
-
Table Southwest China Sildenafil Sales Volume by Application (2018-2023)
-
Table Southwest China Sildenafil Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Sildenafil Sales Volume Share by Application (2018-2023)
-
Table Northwest China Sildenafil Production Volume by Type (2018-2023)
-
Table Northwest China Sildenafil Production Volume Share by Type (2018-2023)
-
Figure Northwest China Sildenafil Production Volume Share by Type (2018-2023)
-
Table Northwest China Sildenafil Sales Volume by Application (2018-2023)
-
Table Northwest China Sildenafil Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Sildenafil Sales Volume Share by Application (2018-2023)
-
Table Viatris Company Profile
-
Table Viatris Sildenafil Revenue, Price and Gross (2018-2023)
-
Table Aurobindo Company Profile
-
Table Aurobindo Sildenafil Revenue, Price and Gross (2018-2023)
-
Table Baiyunshan Pharma Company Profile
-
Table Baiyunshan Pharma Sildenafil Revenue, Price and Gross (2018-2023)
-
Table TEVA Company Profile
-
Table TEVA Sildenafil Revenue, Price and Gross (2018-2023)
-
Table Bristol Laboratories Company Profile
-
Table Bristol Laboratories Sildenafil Revenue, Price and Gross (2018-2023)
-
Table Jiangsu Yabang Epson Pharmaceutical Co, Ltd Company Profile
-
Table Jiangsu Yabang Epson Pharmaceutical Co, Ltd Sildenafil Revenue, Price and Gross (2018-2023)
-
